Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary

Print

Cover Image

PAPERBACK
$36.00

Download

Table of Contents
Front Matter R1-R20
1 Introduction 1-4
2 The Current Landscape 5-16
3 Case Studies 17-28
4 Emerging Technologies in Drug Development 29-36
5 Evolving Paradigms 37-46
6 Forging Collaborative Strategies for the Development of Personalized Medicine 47-54
References 55-58
Appendix A: Workshop Agenda 59-64
Appendix B: Speaker Biographical Sketches 65-80
Appendix C: Statement of Task 81-82
Appendix D: Registered Attendees 83-90

View/Hide Left Panel

5-1 In the current paradigm of drug discovery and development, the approval of a drug rigidly separates the domains of regulators and payers

5-2 In the future, the responsibilities of regulators and payers could overlap, resulting in a dynamic interplay between evidence generation and drug approval

BOXES

1-1 Workshop Objectives

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement